Press Releases for WX

Press Releases
Halter USX China Index Up 61.75% for 2009
Halter USX China Index Up 10.59% for Third Quarter 2009
WuXi PharmaTech Selected as One of the Top Ten Employer for New College Graduates in Pharmaceutical Industry in 2009
WuXi PharmaTech Announces Second-Quarter 2009 Results
WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting
WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology
WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
WuXi PharmaTech Receives Award from BASF
Halter USX China Index Up 40.88% for Second Quarter 2009
WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
WuXi PharmaTech Files 2008 Annual Report on Form 20-F
WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
Golden Dragon Media Inc.: Today's Hottest Alerts Include: WX, ZLC, CYP, MOR, PL, HGR, ZQK
WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
WuXi AppTec Receives 2009 Lilly Global Supplier Award
WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
Wrangler West Reports 2008 Operating and Financial Results
Halter USX China Index Announces First Quarter 2009 Results and Adds New Constituents - Mar 31 2009 8:21PM
WuXi AppTec Bioanalytical Services Unit Passes FDA Inspection
Wrangler West Files NI 51-101 Statement of Reserves Data as at December 31, 2008
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
WuXi AppTec Welcomes Three Senior Professionals
Professor K. C. Nicolaou Speaks at WuXi AppTec
/C O R R E C T I O N -- WuXi PharmaTech (Cayman) Inc./
WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009
WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO
WuXi AppTec Successfully Holds Its 2009 Supplier Conference in Shanghai
WuXi PharmaTech Honored on the Deloitte Technology Fast 500 Asia Pacific 2008 List for the Fifth Consecutive Year
WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
St. Paul and Atlanta Laboratories of WuXi PharmaTech (NYSE:WX) Receive ISO/IEC 17025:2005 Accreditation
WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference
WuXi AppTec Selects H-Cube(R) from ThalesNano for Laboratory-based Hydrogenation
WuXi PharmaTech (NYSE: WX) Holds Its Second Life Science and Chemistry Awards Ceremony in Beijing
WuXi PharmaTech Shanghai Rodent Facility Awarded AAALAC Accreditation
WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
Wrangler West Reports Strong Revenue in 2008 Nine Months
WuXi PharmaTech Appoints Ying Han to Its Board of Directors
WuXi PharmaTech Announces Third Quarter 2008 Results
WuXi PharmaTech Awarded in Deloitte Technology Fast 50 China 2008 List for the Fourth Consecutive Year
WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
WuXi PharmaTech Expands Collaboration for Fully Integrated Services
WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
WuXi PharmaTech Appoints Jeff Leng to Its Board of Directors
WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
Wrangler West Plans Active 2008 Second Half
WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
WuXi PharmaTech Announces Second Quarter 2008 Results
WuXi PharmaTech (NYSE: WX) Appoints Mr. Steven M. Hutchins as VP of Business Development
WuXi PharmaTech Schedules Second Quarter 2008 Earnings Release on Wednesday, August 13, 2008
Venture Forum Highlights the 2008 M&A and IPO's in the Winner's Circle for Healthcare
Warburg Pincus Acquires 5.4% of WuXi PharmaTech's Outstanding Ordinary Shares from United Overseas Bank
Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry
WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
SectorWatch.biz Issues MarketStats on Medical Products and Device Companies INCC, CMED, WX, MR and AOB - Jun 24 2008 7:01AM
WuXi PharmaTech 2007 Annual Report Available Online
SectorWatch.biz Issues MarketStats on Medical Products and Device Companies INCC, CMED, WX, MR and AOB - Jun 16 2008 6:35AM
WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
WuXi PharmaTech Announces First Quarter 2008 Results
WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology
The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX) - May 27 2008 12:43AM
Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars - May 27 2008 12:59AM
Wrangler West Energy Corp. 2008 First Quarter - Forging Ahead
WuXi PharmaTech Schedules First Quarter 2008 Earnings Release on Tuesday, May 27, 2008 - Jun 2 2008 2:49AM
WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering - Jun 2 2008 2:49AM
WuXi PharmaTech (NYSE: WX) Honored Among the BCG 50 Local Dynamos
WuXi PharmaTech (NYSE: WX) Endows a New Faculty Position at Tongji University
WuXi PharmaTech (Cayman) Inc. Announces Filing of Registration Statement For Follow-On and Secondary Offering
WX Crowned 'Chemistry CRO of the Year' by Pfizer